AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Mar, 17, 2023
It can be shown that treatment bringing back indep... See more
Feb, 16, 2023
$AVXL This may show why Anavex is definitely on th... See more
BABA
Alibaba Group Holding Ltd - ADR
-20.42%
$105.11 - $83.65
Feb 8th 2023 - Mar 22nd 2023
Mar, 18, 2023
CCP strongly endorse Alibaba and granted preferential treatment !
Jan, 18, 2023
CURING LEUKEMIA isn't a fly by night thing wit... See more
Divihomes is Now Live
Check out our new advanced search tool that can help you find the best home services in your area.
Search & Match
Instant Communication
Unbiased Reviews
100% Free
SLRX
Salarius Pharmaceuticals Inc
-8.52%
$2.23 - $2.04
Feb 8th 2023 - Mar 22nd 2023
Nov, 10, 2022
$SLRX 'We believe this interim data is an e... See more
Oct, 28, 2022
$SLRX “These initial data explain why we believ... See more
Mar, 17, 2023
It can be shown that treatment bringing back independence is less costly than the nursing homes and medical staff.
Feb, 16, 2023
$AVXL This may show why Anavex is definitely on the right path by using patients personal genetics to determine dosage.
Feb, 16, 2023
Pill = best possible treatment course.
Feb, 14, 2023
Many claim him to be selfish and unconcerned with others, I see a different Missling, with humility and a deep concern for patients who are suffering.
Jan, 24, 2023
Half the patients improved over baseline over 1 year.
Jan, 24, 2023
Blarcamesine’s Phase III clinical trials show similar levels of significant improvement in communication and interaction, as patients had statistically significant improvement in the RSBQ primary endpoint of 72.2% compared to 38.5% on placebo. .
Jan, 22, 2023
And better still for just those 85% carrying the normal SigmaR1 gene as well as for APOE2 and 3 patients.
Jan, 18, 2023
new clinical trial results show great promise for treating early Alzheimer’s, giving renewed hope for effective treatments.
Jan, 17, 2023
Anavex has over 760 patients that have taken it without any significant issues. .
Mar, 18, 2023
CCP strongly endorse Alibaba and granted preferential treatment !
Jan, 18, 2023
CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!
Jan, 18, 2023
CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!
Jan, 18, 2023
CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!
Jan, 18, 2023
CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!
Jan, 18, 2023
CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!
Jan, 18, 2023
CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!
Jan, 18, 2023
CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!
Jan, 17, 2023
CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!
Dec, 27, 2022
but 2023 will see awesome returns on China equities for the patient.
Nov, 10, 2022
$SLRX 'We believe this interim data is an encouraging development for these patients in need of new treatment options and we are looking forward to an additional data update next month.”
Oct, 28, 2022
$SLRX “These initial data explain why we believe SP-3164 is so exciting, with the potential to make a positive difference in the treatment of hematologic cancers.